Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion (Q74152230)
Jump to navigation
Jump to search
scientific article published on 01 June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion |
scientific article published on 01 June 2001 |
Statements
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin (English)
N Kröger
T Zabelina
W Krüger
H Renges
N Stute
J Schrum
H Kabisch
P Schafhausen
N Jaburg
C Löliger
P Schäfer
A Hinke